MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors

Journal of Neurochemistry

Volumn 122, Issue 3, 2012, Pages 582-593

  Zhu, Guoqi ^a   Huang, Yuying ^a   Chen, Ying ^a   Zhuang, Yinghan ^a   Behnisch, Thomas ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

CA1; dopamine; hippocampus; MPTP; Parkinson's disease; synaptic plasticity

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; DOPAMINE RECEPTOR; ETICLOPRIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SULPIRIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ELECTROENCEPHALOGRAM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT TERM POTENTIATION; SYNAPTIC TRANSMISSION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZAZEPINES; BIOPHYSICS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEURONS; NEUROTOXINS; PATCH-CLAMP TECHNIQUES; QUINOXALINES; RECEPTORS, DOPAMINE; SODIUM CHANNEL BLOCKERS; SULPIRIDE; TETRODOTOXIN; TIME FACTORS; VALINE;

EID: 84863722296     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07815.x     Document Type: Article

References (59)

1. Alex M., (2000) Facilitation, augmentation and potentiation at central synapses. Trends Neurosci. 23, 305-312.
2. Behnisch T., and, Reymann K. G., (1994) 2,3-diphosphoglyceric acid blocks long-term potentiation of excitatory postsynaptic currents in hippocampal CA1 neurons of the rat. Neurosci. Lett. 165, 23-26.
3. Behnisch T., Wilsch V. W., Balschun D., and, Reymann K. G., (1998) The role of group II metabotropic glutamate receptors in hippocampal CA1 long-term potentiation in vitro. Eur. J. Pharmacol. 356, 159-165.
4. Behnisch T., YuanXiang P., Bethge P., Parvez S., Chen Y., Yu J., Karpova A., Frey J. U., Mikhaylova M., and, Kreutz M. R., (2011) Nuclear Translocation of Jacob in Hippocampal Neurons after Stimuli Inducing Long-Term Potentiation but Not Long-Term Depression. PLoS ONE 6, e17276.
5. Behr J., Gloveli T., Schmitz D., and, Heinemann U., (2000) Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic D1-like dopamine receptors. J. Neurophysiol. 84, 112-119.
6. Bliss T. V., and, Collingridge G. L., (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
7. Bove J., Prou D., Perier C., and, Przedborski S., (2005) Toxin-induced models of Parkinson's disease. NeuroRx. 2, 484-494.
8. Cai F., Frey J. U., Sanna P. P., and, Behnisch T., (2010) Protein degradation by the proteasome is required for synaptic tagging and the heterosynaptic stabilization of hippocampal late-phase long-term potentiation. Neuroscience 169, 1520-1526.
9. Chen Y., YuanXiang P., Knopfel T., Thomas U., and, Behnisch T., (2012) Hippocampal LTP triggers proteasome-mediated SPAR degradation in CA1 neurons. Synapse 66, 142-150.
10. Chergui K., Svenningsson P., and, Greengard P., (2004) Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl. Acad. Sci. USA 101, 2191-2196.
11. Di Monte D. A., (2003) The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2, 531-538.
12. Ekelund J., Slifstein M., Narendran R., Guillin O., Belani H., Guo N. N., Hwang Y., Hwang D. R., bi-Dargham A., and, Laruelle M., (2007) In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol. Imaging Biol. 9, 117-125.
13. Floran B., Floran L., Erlij D., and, Aceves J., (2004) Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus. Eur. J. Pharmacol. 498, 97-102.
14. Frey U., Schroeder H., and, Matthies H., (1990) Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices. Brain Res. 522, 69-75.
15. Fuller R. W., Hemrick-Luecke S. K., and, Perry K. W., (1989) Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to mice. Life Sci. 45, 2077-2083.
16. Galvan M., Kupsch A., and, Tenbruggencate G., (1987) Actions of Mptp and Mpp+ on Synaptic Transmission in Guinea-Pig Hippocampal Slices. Exp. Neurol. 96, 289-298.
17. Gasbarri A., Verney C., Innocenzi R., Campana E., and, Pacitti C., (1994) Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res. 668, 71-79.
18. Goebel-Goody S. M., Davies K. D., vestad Linger R. M., Freund R. K., and, Browning M. D., (2009) Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience 158, 1446-1459.
19. Goldsmith S. K., and, Joyce J. N., (1994) Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4, 354-373.
20. Hasbani D. M., and, O'Malley K. L., (2006) WldS mice are protected against the Parkinsonian mimetic MPTP. Exp. Neurol. 202, 93-99.
21. Hsu K. S., (1996) Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice. J. Neurophysiol. 76, 1887-1895.
22. Huang Y. Y., and, Kandel E. R., (1995) D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. USA 92, 2446-2450.
23. Inazu M., Kubota N., Takeda H., Oguchi K., Koizumi M., Kimura S., and, Matsumiya T., (2001) Methyl-4-phenylpyridinium (MPP(+))-evoked dopamine release from rat striatal slices: possible roles of voltage-dependent calcium channels and reverse dopamine transport. Neurochem. Int. 39, 253-260.
24. Jacksonlewis V., Jakowec M., Burke R. E., and, Przedborski S., (1995) Time-Course and Morphology of Dopaminergic Neuronal Death Caused by the Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine. Neurodegeneration 4, 257-269.
25. Jay T. r. s. M., (2003) Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 69, 375-390.
26. Kang M. J., Gil S. J., Lee J. E., and, Koh H. C., (2010) Selective vulnerability of the striatal subregions of C57BL/6 mice to paraquat. Toxicol. Lett. 195, 127-134.
27. Kopin I. J., (1987) MPTP: An Industrial Chemical and Contaminant of Illicit Narcotics Stimulates a New Era in Research on Parkinson's Disease. Environ. Health Perspect. 75, 45-51.
28. Liou H. H., Tsai M. C., Chen C. J., Jeng J. S., Chang Y. C., Chen S. Y., and, Chen R. C., (1997) Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48, 1583-1588.
29. Lisman J. E., and, Grace A. A., (2005) The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46, 703-713.
30. Martelle J. L., and, Nader M. A., (2008) A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS. Neurosci. Ther. 14, 248-262.
31. Mikhaylova M., Vakhitova J. V., Yamidanov R. S., Salimgareeva M. K., Seredenin S. B., and, Behnisch T., (2007) The effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats. Neuropharmacology 53, 601-608.
32. Morris R. G., (2006) Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas. Eur. J. Neurosci. 23, 2829-2846.
33. Muralikrishnan D., and, Mohanakumar K. P., (1998) Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. FASEB J 12, 905-912.
34. Navakkode S., Sajikumar S., and, Frey J. U., (2007) Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro. Neuropharmacology 52, 1547-1554.
35. Nicotra A., and, Parvez S., (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol. Teratol. 24, 599-605.
36. Oh-Nishi A., Saji M., Furudate S. I., and, Suzuki N., (2005) Dopamine D(2)-like receptor function is converted from excitatory to inhibitory by thyroxine in the developmental hippocampus. J. Neuroendocrinol. 17, 836-845.
37. Otmakhova N. A., and, Lisman J. E., (1996) D1/D5 Dopamine Receptor Activation Increases the Magnitude of Early Long-Term Potentiation at CA1 Hippocampal Synapses. J. Neurosci. 16, 7478-7486.
38. Otmakhova N. A., and, Lisman J. E., (1999) Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region. J. Neurosci. 19, 1437-1445.
39. Prediger R. D., Aguiar A. S. Jr., Rojas-Mayorquin A. E., et al. (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease. Neurotox. Res. 17, 114-129.
40. Przedborski S., Jackson-Lewis V., Naini A. B., Jakowec M., Petzinger G., Miller R., and, Akram M., (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. 76, 1265-1274.
41. Ren J. P., Zhao Y. W., and, Sun X. J., (2009) Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice. Chin. Med. J. (Engl.) 122, 2366-2371.
42. Reymann K. G., and, Frey J. U., (2006) The late maintenance of hippocampal LTP: Requirements, phases, 'synaptic tagging', 'late-associativity' and implications. Neuropharmacology 52, 24-40.
43. Rodriguez-Oroz M. C., Jahanshahi M., Krack P., Litvan I., Macias R., Bezard E., and, Obeso J. A., (2009) Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol. 8, 1128-1139.
44. Sarantis K., Matsokis N., and, Angelatou F,. (2009) Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: Involvement of ERK1/2 signaling. Neuroscience 163, 1135-1145.
45. Scott L., and, Aperia A., (2009) Interaction between N-methyl-d-aspartic acid receptors and D1 dopamine receptors: An important mechanism for brain plasticity. Neuroscience 158, 62-66.
46. Serulle Y., Morfini G., Pigino G., Moreira J. E., Sugimori M., Brady S. T., and, Llinas R. R., (2007) 1-Methyl-4-Phenylpyridinium Induces Synaptic Dysfunction through a Pathway Involving Caspase and PKCdelta Enzymatic Activities. Proc. Nat. Acad. Sci. USA 104, 2437-2441.
47. Stephenson J., (2000) Exposure to home pesticides linked to Parkinson disease. Jama-Journal of the American Medical Association 283, 3055-3056.
48. Sun F., Kanthasamy A., Anantharam V., and, Kanthasamy A. G., (2007a) Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease. Pharmacol. Ther. 114, 327-344.
49. Sun M., Thomas M. J., Herder R., Bofenkamp M. L., Selleck S. B., and, O'Connor M. B., (2007b) Presynaptic contributions of chordin to hippocampal plasticity and spatial learning. J. Neurosci. 27, 7740-7750.
50. Swant J., Chirwa S., Stanwood G., and, Khoshbouei H., (2010) Methamphetamine Reduces LTP and Increases Baseline Synaptic Transmission in the CA1 Region of Mouse Hippocampus. PLoS ONE 5, e11382.
51. Tanner C. M., Kamel F., Ross G. W., et al. (2011) Rotenone, Paraquat and Parkinson's Disease. Environ. Health Perspect. 119, 866-872.
52. Trempe J. F., Chen C. X., Grenier K., Camacho E. M., Kozlov G., McPherson P. S., Gehring K., and, Fon E. A., (2009) SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination. Mol. Cell 36, 1034-1047.
53. Trepanier C. H., Jackson M. F., and, MacDonald J. F., (2012) Regulation of NMDA receptors by the tyrosine kinase Fyn. FEBS J. 279, 12-19.
54. Wilsch V. W., Behnisch T., Jäger T., Reymann K. G., and, Balschun D., (1998) When are class I metabotropic glutamate receptors necessary for long-term potentiation? J. Neurosci. 18, 6071-6080.
55. Wu W. L., Burnett D. A., Spring R., Greenlee W. J., Smith M., Favreau L., Fawzi A., Zhang H., and, Lachowicz J. E., (2005) Dopamine D1/D5 Receptor Antagonists with Improved Pharmacokinetics: Design, Synthesis, and Biological Evaluation of Phenol Bioisosteric Analogues of Benzazepine D1/D5 Antagonists. J. Med. Chem. 48, 680-693.
56. Yang S. C., Johannessen J. N., and, Markey S. P., (1988) Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin. Chem. Res. Toxicol. 1, 228-233.
57. Zhang J. C., Lau P. M., and, Bi G. Q., (2009) Gain in sensitivity and loss in temporal contrast of STDP by dopaminergic modulation at hippocampal synapses. Proc. Natl. Acad. Sci. USA 106, 13028-13033.
58. Zhen X., Torres C., Cai G., and, Friedman E., (2002) Inhibition of Protein Tyrosine/Mitogen-Activated Protein Kinase Phosphatase Activity Is Associated with D2 Dopamine Receptor Supersensitivity in a Rat Model of Parkinson's Disease. Mol. Pharmacol. 62, 1356-1363.
59. Zhu G., Chen Y., Huang Y., Li Q., and, Behnisch T., (2011) MPTP-meditated hippocampal dopamine deprivation modulates synaptic transmission and activity-dependent synaptic plasticity. Toxicol. Appl. Pharmacol. 254, 332-341.